Ticker brief
BSX BOSTON SCIENTIFIC CORP
Consumer, Non-cyclical · Healthcare-Products
last close
$45.69
1 day
-0.7%
14 days
+6.9%
mkt cap
$67.1B
signals 14d
21
authors 14d
19
crowd 14d
-0.0σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 49% rich · 89 pctile own 1y | IV/HV 1.64× |
| Skew — 25Δ RR 30d | -0.007 72 pctile own 1y | balanced vs own range |
| Net dealer OI (NDOI) | +0.08 normal | 5-session Δ +0.23 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-05-29 (z=20.6) |
| Next earnings | 2026-10-28 (proj) | in 2d |
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-13 · now -0.30 (−1 bearish … +1 bullish)
Who spoke19
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @WOLF_Financial | C | -3.03 | 2 | -0.14 |
| @_inpractise | B | +0.29 | 2 | -0.05 |
| @DeItaone | B | +0.84 | 1 | +0.30 |
| @RealNickMugalli | B | +0.06 | 1 | +0.40 |
| @JoshTradeOption | C | +0.02 | 1 | +0.15 |
| @DividendDynasty | C | +0.40 | 1 | +0.35 |
| @theflynews | C | · | 1 | +0.10 |
| @VanIsleInvestor | B | +1.76 | 1 | -0.10 |
| @HunterAllen4 | C | -2.09 | 1 | +0.20 |
| @twinsight_x | C | +2.87 | 1 | -0.65 |
| @OpenOutcrier | C | · | 1 | +0.25 |
| @KeithTradeSmith | C | +1.08 | 1 | -0.40 |
| @Tickeron | C | +1.53 | 1 | +0.70 |
| @ALEXEIMARTOV | A | -0.66 | 1 | +0.15 |
| @Mindset4Money_X | C | -0.74 | 1 | +0.60 |
| @davevermilion | A | -0.54 | 1 | +0.30 |
| @VladBastion | B | -0.16 | 1 | +0.00 |
| @jonbking | C | +0.51 | 1 | -0.55 |
| @StockWorthyApp | C | -0.77 | 1 | -0.35 |
Recent signals21of 21 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-13 | @StockWorthyApp | -0.35 | Quantifies declines for stocks near 52-week lows; ticker list is capped at the first six. | +5.5% | tweet ↗ |
| 2026-10-13 | @jonbking | -0.55 | Contrasts BSX's drawdown, PG's value setup below its 200-week average and a recent GME rally. | +5.5% | tweet ↗ |
| 2026-10-13 | @VladBastion | +0.00 | Screens fallen S&P growers using revenue growth, valuation, momentum and one-year performance. | +5.5% | tweet ↗ |
| 2026-10-12 | @davevermilion | +0.30 | Says the author will remain in BSX while observing broader developments. | +4.2% | tweet ↗ |
| 2026-10-12 | @Mindset4Money_X | +0.60 | Frames BSX's low valuation and substantial insider buying as a possible opportunity. | +4.2% | tweet ↗ |
| 2026-10-12 | @_inpractise | +0.25 | Points to former strategy manager commentary on Boston Scientific's next growth driver. | +4.2% | tweet ↗ |
| 2026-10-12 | @WOLF_Financial | +0.27 | Summarizes the day's leading stock gains and sector rotation. | +4.2% | tweet ↗ |
| 2026-10-12 | @ALEXEIMARTOV | +0.15 | MedTech valuations look better, but high rates, competition and procedure risks temper optimism. | +4.2% | tweet ↗ |
| 2026-10-11 | @_inpractise | -0.35 | Cites a former Boston Scientific executive on Chinese price competition. | +6.9% | tweet ↗ |
| 2026-10-10 | @Tickeron | +0.70 | Buy selected fallen S&P 500 stocks while avoiding names viewed as value traps. — Assigns explicit BUY or SELL views to deeply fallen stocks with supporting theses. | +6.9% | tweet ↗ |
| 2026-10-10 | @WOLF_Financial | -0.55 | Ranks the worst-performing S&P 500 stocks in 2026 and gives their year-to-date losses. | +6.9% | tweet ↗ |
| 2026-10-09 | @KeithTradeSmith | -0.40 | Identifies capital rotation into tankers and software and away from healthcare and gaming. | +6.9% | tweet ↗ |
| 2026-10-08 | @OpenOutcrier | +0.25 | Recaps unusual call positioning; tickers are capped at the first six listed. | +8.7% | tweet ↗ |
| 2026-10-08 | @twinsight_x | -0.65 | Reports BSX at a fresh 52-week low and down roughly 61%, while JNJ is off 1%. | +8.7% | tweet ↗ |
| 2026-10-08 | @HunterAllen4 | +0.20 | Watchlist analysis identifies a double bottom, support base and downside zone without entry intent. | +8.7% | tweet ↗ |
| 2026-10-07 | @VanIsleInvestor | -0.10 | BSX named a new COO and announced a reorganization amid prior guidance cuts and disruption. | +9.9% | tweet ↗ |
| 2026-10-07 | @theflynews | +0.10 | Boston Scientific appointed Joseph Fitzgerald as chief operating officer. | +9.9% | tweet ↗ |
| 2026-10-06 | @DividendDynasty | +0.35 | Highlights BSX as a potential opportunity based on drawdown, EPS growth and valuation. | +8.3% | tweet ↗ |
| 2026-10-05 | @JoshTradeOption | +0.15 | Recaps premiums already collected from seven options trades; output is capped at six tickers. | +7.8% | tweet ↗ |
| 2026-10-05 | @RealNickMugalli | +0.40 | Citi adds four medtech stocks to its 90-day Upside Catalyst Watch. | +7.8% | tweet ↗ |
| 2026-10-05 | @DeItaone | +0.30 | Citi adds four healthcare stocks to its 90-day upside catalyst watch list. | +7.8% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.